Vol.

No.

December 01, 2023Dec 01, 2023

DOWNLOAD THE PDF

Cover Story

NCI needs a $250M raise in FY24 to maintain paylines, grant funding levels amid crippling continuing resolutions

By Matthew Bin Han Ong

The gridlock in Washington is taking a toll on federally funded cancer research as the partisan wrangling in Congress over border security and funding for Israel and Ukraine shows no sign of relenting.

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media

By Paul Goldberg

Conversation with The Cancer Letter

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

By Paul Goldberg

Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel

By Alexandria Carolan

Guest Editorial

For cancer patients, traditional Medicare is better than Medicare Advantage

By Hagop M. Kantarjian and Mary Alma Welch

Free Obituary

Worta McCaskill-Stevens understood the importance of explaining cancer prevention

By Otis W. Brawley and Lucile L. Adams-Campbell

Free Obituary

Worta McCaskill-Stevens, MD: An appreciation for a driving force in cancer prevention and addressing cancer disparities

By Division of Cancer Prevention staff

Free In the Archives

110 years of the American Cancer Society

In Brief

Eduardo Sotomayor named vice president and executive director of Tampa General Hospital’s Cancer Institute

Glenn Lesser named deputy director of the Atrium Health Wake Forest Baptist CCC

Sarki Abdulkadir, Patricia Robinson named to senior leadership positions at Northwestern

Louise Ligresti named chief of cancer survivorship at Rutgers Cancer Institute

Morhaf Al Achkar named associate center director for education at Karmanos

Bryan Burt named chief of thoracic surgery at UCLA Health

Sora Ely joins GW Cancer Center’s Thoracic Oncology Program

Kornelia Polyak, Alana Welm to receive awards at San Antonio Breast Cancer Symposium

Ethan Basch receives $3M grant to launch national patient-reported outcomes project

Andrew Frankart receives $729,000 ACS/ASTRO Clinician Scientist Development Grant

Lung cancer screening clinic opens at UNM

CRUK publishes manifesto to avoid 20,000 cancer deaths a year by 2040

Funding Opportunities

TGen establishes fellowship program in GBM

Clinical Roundup

FDA investigating serious risk of T-cell malignancy following BCMA-directed or CD19-directed autologous CAR T-cell immunotherapies

Phase III trial produces positive results for Blenrep in R/R MM

ChristianaCare researchers find disparities in breast cancer screening in Delaware linked to race and geography

Experimental drug combination shows promise against hard-to-treat peripheral nerve sheath tumors

Conventional age-based guidelines for CRC screening do not account for health status, life expectancy, UT Southwestern researchers find

Liver cancer rates are rising with each successive generation of Mexican Americans, study finds

Drugs & Targets

FDA approves Xtandi for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

FDA grants Breakthrough Therapy Designation to epcoritamab-bysp

NCI Trials

NCI Trials for December 2023

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 33 - September 12, 2025